Pfizer raises 2026 guidance after Q3, reports pipeline progress and new CFONov 3Quarterly updateBioNTech SEC4 Therapeutics, Inc.
NeuroSense seeks US patent for PrimeC in traumatic brain injuryOct 19Regulatory decisionNeuroSense Therapeutics Ltd.
BeOne Medicines registers Phase 1 drug interaction trial for CDK4 inhibitor BGB-43395Sep 15Trial updateBeiGene
Sign inSign in